自身免疫性肝病患者黏膜相关恒定T细胞慢性活化并促进促纤维化肝星状细胞活化
研究分析自身免疫性肝病患者与健康对照的黏膜相关恒定T(MAIT)细胞表型与功能,并探讨其与人原代肝星状细胞(hHSC)的相互作用。结果显示患者外周血和肝组织MAIT细胞显著减少,呈耗竭表型,反复IL-12/IL-18刺激可诱导该状态并表达促纤维化IL-17A,MAIT细胞可部分经IL-17介导诱导hHSC活化、促炎和促纤维化表型。
要点
- 自身免疫性肝病患者外周血和肝组织MAIT细胞显著减少,且MAIT细胞频率随纤维化分期增加呈下降趋势。
- 患者MAIT细胞呈耗竭表型:IFN-γ产生受损,CD38、HLA-DR、CTLA-4表达升高。
- 反复IL-12和IL-18刺激可诱导MAIT细胞耗竭,反复IL-12刺激还使耗竭MAIT细胞表达促纤维化IL-17A。
核心结论
- 自身免疫性肝病患者的MAIT细胞向耗竭、促纤维化表型演化,可促进肝星状细胞介导的肝纤维化发生。
- 该发现揭示了自身免疫性肝病纤维化发生的细胞与分子通路,可能用于抗纤维化治疗。
研究设计与样本
- 研究采用多色流式细胞术分析自身免疫性肝病患者与健康对照的MAIT细胞表型和功能。
- 研究体外探讨人MAIT细胞与人原代肝星状细胞(hHSC)的相互作用。
主要发现
- MAIT细胞在自身免疫性肝病患者外周血和肝组织中显著减少。
- MAIT细胞频率随纤维化分期增加呈下降趋势。
- 患者MAIT细胞IFN-γ产生受损,CD38、HLA-DR和CTLA-4的离体表达升高。
- 反复IL-12和IL-18刺激可诱导MAIT细胞IFN-γ减少、耗竭标志物表达增加。
- 反复IL-12刺激使耗竭MAIT细胞表达促纤维化细胞因子IL-17A。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Autoimmune liver diseases (AILDs) are chronic liver pathologies characterized by fibrosis and cirrhosis due to immune-mediated liver damage. In this study, we addressed the question whether mucosal-associated invariant T (MAIT) cells, innate-like T cells, are functionally altered in patients with AILD and whether MAIT cells can promote liver fibrosis through activation of hepatic stellate cells (HSCs). We analyzed the phenotype and function of MAIT cells from AILD patients and healthy controls by multicolor flow cytometry and investigated the interaction between human MAIT cells and primary human hepatic stellate cells (hHSCs). We show that MAIT cells are significantly decreased in peripheral blood and liver tissue of patients with AILD. Notably, MAIT cell frequency tended to decrease with increasing fibrosis stage. MAIT cells from AILD patients showed signs of exhaustion, such as impaired interferon-γ (IFN-γ) production and high ex vivo expression of the activation and exhaustion markers CD38, HLA-DR, and CTLA-4. Mechanistically, this exhausted state could be induced by repetitive stimulation of MAIT cells with the cytokines interleukin (IL)-12 and IL-18, leading to decreased IFN-γ and increased exhaustion marker expression. Of note, repetitive stimulation with IL-12 further resulted in expression of the profibrogenic cytokine IL-17A by otherwise exhausted MAIT cells. Accordingly, MAIT cells from both healthy controls and AILD patients were able to induce an activated, proinflammatory and profibrogenic phenotype in hHSCs in vitro that was partly mediated by IL-17. CONCLUSION: Our data provide evidence that MAIT cells in AILD patients have evolved towards an exhausted, profibrogenic phenotype and can contribute to the development of HSC-mediated liver fibrosis. These findings reveal a cellular and molecular pathway for fibrosis development in AILD that could be exploited for antifibrotic therapy. (Hepatology 2018;68:172-186).
引用
- Böttcher K, Rombouts K, Saffioti F, et al. MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation. Hepatology. 2018. PMID: 29328499. doi:10.1002/hep.29782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。